Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
Ursolic acid (UA) is a triterpene with a broad array of pharmacological activities. In leishmaniasis, UA killed different species of parasites, and it was active in the experimental model of cutaneous and visceral leishmaniasis. Thus, the objective of this work was to study the therapeutic efficacy...
Main Authors: | Jéssica Adriana Jesus, Thays Nicolli Fragoso da Silva, Eduardo Seiji Yamamoto, João Henrique G. Lago, Márcia Dalastra Laurenti, Luiz Felipe Domingues Passero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/9/10/855 |
Similar Items
-
Visceral leishmaniasis in children
by: mandana Rafeey, et al.
Published: (2005-02-01) -
Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01) -
HISTORICAL SERIES OF PATIENTS WITH VISCERAL LEISHMANIASIS TREATED WITH MEGLUMINE ANTIMONIATE IN A HOSPITAL FOR TROPICAL DISEASES, MACEIÓ-AL, BRAZIL
by: Lindon Johoson Diniz Silveira, et al.
Published: (2015-02-01) -
Comparison of Th1 and Th2 Responses in Non-Healing and Healing Patients with Cutaneous Leishmaniasis
by: Maryam Shahi, et al.
Published: (2013-05-01) -
Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)